Ratings by TD Cowen (Matthew Blackman)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/19/2026 | Intuitive Surgical | ISRG | Maintain | Buy (N/A) |
|
Details | ||
| 9/22/2026 | Stryker | SYK | Maintain | Hold (N/A) |
|
Details | ||
| 8/6/2026 | Insulet Corporation | PODD | Maintain | Hold (N/A) |
|
Details | ||
| 8/5/2026 | Alphatec Holdings | ATEC | Maintain | Buy (N/A) |
|
Details | ||
| 8/4/2026 | SI-BONE Inc. | SIBN | Maintain | Buy (N/A) |
|
Details | ||
| 7/17/2026 | Intuitive Surgical | ISRG | Maintain | Buy (N/A) |
|
Details | ||
| 7/13/2026 | Intuitive Surgical | ISRG | Maintain | Buy (N/A) |
|
Details | ||
| 5/12/2026 | SI-BONE Inc. | SIBN | Maintain | Buy (N/A) |
|
Details | ||
| 5/6/2026 | Alphatec Holdings | ATEC | Maintain | Buy (N/A) |
|
Details | ||
| 5/1/2026 | Stryker | SYK | Maintain | Hold (N/A) |
|
Details | ||
| 4/20/2026 | Tandem Diabetes Care | TNDM | Maintain | Buy (N/A) |
|
Details | ||
| 2/25/2026 | Globus Medical | GMED | Maintain | Buy (N/A) |
|
Details | ||
| 2/24/2026 | SI-BONE Inc. | SIBN | Maintain | Buy (N/A) |
|
Details | ||
| 1/27/2026 | Alphatec Holdings | ATEC | Maintain | Buy (N/A) |
|
Details | ||
| 1/27/2026 | SI-BONE Inc. | SIBN | New Coverage | Buy (N/A) |
16.80 (19.73) |
17.44% | Details | |
| 1/27/2026 | Alphatec Holdings | ATEC | New Coverage | Buy (N/A) |
15.62 (10.42) |
-33.29% | Details | |
| 1/27/2026 | Globus Medical | GMED | New Coverage | Buy (N/A) |
92.52 (75.73) |
-18.15% | Details | |
| 1/27/2026 | Tandem Diabetes Care | TNDM | New Coverage | Buy (N/A) |
19.90 (16.20) |
-18.59% | Details | |
| 1/27/2026 | Zimmer Biomet | ZBH | New Coverage | Buy (N/A) |
86.60 (95.07) |
9.78% | Details | |
| 1/27/2026 | Insulet Corporation | PODD | New Coverage | Hold (N/A) |
271.60 (141.41) |
-47.93% | Details | |
| 1/27/2026 | Intuitive Surgical | ISRG | New Coverage | Buy (N/A) |
523.99 (432.92) |
-17.38% | Details |
